Four of the eight cohorts (included in the seven studies) with CSF p-tau data reported significantly lower levels of p-tau in the PSP cohorts compared to the control subjects, with the remaining studies not reporting significant differences between the two groups. Here, MAPT is linked to supranuclear palsy, progressive, 1.